Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes
Open Access
- 13 November 2013
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (12) , 4098-4103
Abstract
Ketosis-prone diabetes (KPD) is characterized by diabetic ketoacidosis (DKA) in patients lacking typical features of type 1 diabetes. A validated classification scheme for KPD includes two autoantibody-negative ("A-") phenotypic forms: "A-β-" (lean, early onset, lacking β-cell functional reserve) and "A-β+" (obese, late onset, with substantial β-cell functional reserve after the index episode of DKA). Recent longitudinal analysis of a large KPD cohort revealed that the A-β+ phenotype includes two distinct subtypes distinguished by the index DKA episode having a defined precipitant ("provoked," with progressive β-cell function loss over time) or no precipitant ("unprovoked," with sustained β-cell functional reserve). These three A- KPD subtypes are characterized by absence of humoral islet autoimmune markers, but a role for cellular islet autoimmunity is unknown. Islet-specific T-cell responses and the percentage of proinflammatory (CD14+CD16+) blood monocytes were measured in A-β- (n = 7), provoked A-β+ (n = 15), and unprovoked A-β+ (n = 13) KPD patients. Genotyping was performed for type 1 diabetes-associated HLA class II alleles. Provoked A-β+ and A-β- KPD patients manifested stronger islet-specific T-cell responses (P < 0.03) and higher percentages of proinflammatory CD14+CD16+ monocytes (P < 0.01) than unprovoked A-β+ KPD patients. A significant relationship between type 1 diabetes HLA class II protective alleles and negative T-cell responses was observed. Provoked A-β+ KPD and A-β- KPD are associated with a high frequency of cellular islet autoimmunity and proinflammatory monocyte populations. In contrast, unprovoked A-β+ KPD lacks both humoral and cellular islet autoimmunity.Keywords
This publication has 22 references indexed in Scilit:
- Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic PatientsDiabetes Care, 2010
- ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onsetAutoimmunity, 2010
- Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of “A-β+” ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilectionMetabolism, 2010
- HLA Class II Alleles Specify Phenotypes of Ketosis-Prone DiabetesDiabetes Care, 2008
- T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe β-Cell Lesions in Phenotypic Type 2 DiabetesDiabetes, 2007
- Accuracy and Predictive Value of Classification Schemes for Ketosis-Prone DiabetesDiabetes Care, 2006
- The CD14+ CD16+ blood monocytes: their role in infection and inflammationJournal of Leukocyte Biology, 2006
- Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with β-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism, 2006
- Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 DiabetesDiabetes, 2006
- Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and β-Cell Functional Classification, Prospective Analysis, and Clinical OutcomesThe Journal of Clinical Endocrinology & Metabolism, 2003